Literature DB >> 23450974

National Oncology Practice Benchmark, 2012 report on 2011 data.

Elaine L Towle1, Thomas R Barr, James L Senese.   

Abstract

Mesh:

Year:  2012        PMID: 23450974      PMCID: PMC3500485          DOI: 10.1200/JOP.2012.000735

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  1 in total

1.  Oncology practice trends from the national practice benchmark.

Authors:  Thomas R Barr; Elaine L Towle
Journal:  J Oncol Pract       Date:  2012-09       Impact factor: 3.840

  1 in total
  6 in total

1.  Improving outpatient oncology practice: several steps into a long journey.

Authors:  Rena M Conti; Peter B Bach
Journal:  J Oncol Pract       Date:  2014-10-14       Impact factor: 3.840

2.  Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.

Authors:  Blase N Polite; Jeffery C Ward; John V Cox; Roscoe F Morton; John Hennessy; Ray D Page; Rena M Conti
Journal:  J Oncol Pract       Date:  2014-11       Impact factor: 3.840

3.  Problems with public reporting of cancer quality outcomes data.

Authors:  Paul Goldberg; Rena M Conti
Journal:  J Oncol Pract       Date:  2014-05       Impact factor: 3.840

4.  Expanding the Scope of the National Practice Oncology Benchmark Would Be a Critical Source for Understanding Outpatient Oncology Practice Costs and Profits in a Time of Change.

Authors:  Rena M Conti
Journal:  J Oncol Pract       Date:  2015-01       Impact factor: 3.840

5.  The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities.

Authors:  Rena M Conti; Peter B Bach
Journal:  Health Aff (Millwood)       Date:  2014-10       Impact factor: 6.301

6.  Prevalence of hypercalcemia among cancer patients in the United States.

Authors:  Victor M Gastanaga; Lee S Schwartzberg; Rajul K Jain; Melissa Pirolli; David Quach; Jane M Quigley; George Mu; W Scott Stryker; Alexander Liede
Journal:  Cancer Med       Date:  2016-06-05       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.